Burrill Associates

Burrill & Company was a prominent San Francisco-based venture capital and investment banking firm dedicated exclusively to the life sciences industry. Founded in 1994 by G. Steven Burrill, the firm played a pivotal role in the growth of the biotechnology sector through its diverse investment funds and the publication of the widely read "Burrill Report." The company provided a range of services including venture capital, merchant banking, and media/events for the global healthcare community. At its peak, the firm managed over $1 billion in assets and was considered a cornerstone of the biotech investment landscape. In 2014, the firm effectively collapsed following a scandal involving the misappropriation of fund capital, leading to SEC charges against its founder.